Pharmacokinetics and tissue penetration of vancomycin continuous infusion as prophylaxis for vascular surgery

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 11, 2011, Pages 2624-2627

  Payne, Christopher J ^a   Thomson, Alison H ^b,c   Stearns, Adam T ^a   Watson, David G ^c   Zhang, Tong ^c   Kingsmore, David B ^a   Byrne, Dominique S ^a   Binning, Alexander S ^b  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Glycopeptides; Surgical prophylaxis; Tissue distribution

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTERY RECONSTRUCTION; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PENETRATION; HUMAN; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY; LOADING DRUG DOSE; TANDEM MASS SPECTROMETRY; TISSUE SECTION; VASCULAR SURGERY;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ARTERIES; HUMANS; INFUSIONS, INTRAVENOUS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS-RELATED INFECTIONS; SUBCUTANEOUS FAT; VANCOMYCIN; VASCULAR SURGICAL PROCEDURES;

EID: 80054705307     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr326     Document Type: Article

References (18)

1. Seeger JM. Management of patients with prosthetic vascular graft infection. Am Surg 2000; 66: 166-77.
2. Chambers ST. Diagnosis and management of staphylococcal infections of vascular grafts and stents. Intern Med J 2005; 35 Suppl 2: S72-8.
3. Naylor AR, Hayes PD, Darke S. A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur J Vasc Endovasc Surg 2001; 21: 289-94.
4. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189: 395-404.
5. Gemmell CG, Edwards DI, Fraise AP et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 2006; 57: 589-608.
6. Payne CJ, Carmichael SJ, Stearns AT et al. Vancomycin continuous infusion as prophylaxis for vascular surgery. Ther Drug Monit 2009; 31: 786-8.
7. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
8. Zhang T, Watson DG, Azike C et al. Determination of vancomycin in serum by liquid chromatography-high resolution full scan mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 857: 352-6.
9. Albanèse J, Léone M, Bruguerolle B et al. Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother 2000; 44: 1356-8.
10. Cruciani M, Gatti G, Lazzarini L et al. Penetration of vancomycin into human lung tissue. J Antimicrob Chemother 1996; 38: 865-9.
11. Luzzati R, Sanna A, Allegranzi B et al. Pharmacokinetics and tissue penetration of vancomycin in patients undergoing prosthetic mammary surgery. J Antimicrob Chemother 2000; 45: 243-5.
12. Martin C, Alaya M, Mallet MN et al. Penetration of vancomycin into mediastinal and cardiac tissues in humans. Antimicrob Agents Chemother 1994; 38: 396-9.
13. Kitzes-Cohen R, Farin D, Piva G et al. Pharmacokinetics of vancomycin administered as prophylaxis before cardiac surgery. Ther Drug Monit 2000; 22: 661-7.
14. Massias L, Dubois C, de Lentdecker P et al. Penetration of vancomycin in uninfected sternal bone. Antimicrob Agents Chemother 1992; 36: 2539-41.
15. Skhirtladze K, Hutschala D, Fleck T et al. Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery. Antimicrob Agents Chemother 2006; 50: 1372-5.
16. Daschner FD, Frank U, Kümmel A et al. Pharmacokinetics of vancomycin in serum and tissue of patients undergoing open-heart surgery. J Antimicrob Chemother 1987; 19: 359-62.
17. Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in nonvancomycin-intermediate Staphylococcus aureus (VISA), vancomycinsusceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 2007; 60: 788-94.
18. Kralovic SM, Danko LH, Roselle GA. Laboratory reporting of Staphylococcus aureus with reduced susceptibility to vancomycin in United States Department of Veterans Affairs facilities. Emerg Infect Dis 2002; 8: 402-7.